Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationCyclophosphamideMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeStem CellsLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceIfosfamideCarmustineCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineTissue DonorsTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationInfectionBlood Cell CountHistocompatibilityBlood CellsPlatelet CountPOEMS SyndromeTime FactorsSurvival AnalysisDoxorubicinHistocompatibility TestingLymphoma, T-CellImmunosuppressive AgentsVidarabineTransplantation, IsogeneicCarboplatinLeukemia, Myeloid, AcuteBone Marrow PurgingRecombinant ProteinsLeukemiaPrednisoneDexamethasoneLymphomaFollow-Up StudiesCytomegalovirus InfectionsFeasibility StudiesProspective StudiesGraft vs Leukemia EffectAntineoplastic AgentsImmunophenotypingFatal OutcomeBlood DonorsLeukocytes, MononuclearAnemia, AplasticMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionBone MarrowCell SeparationT-LymphocytesHistiocytosis, Non-Langerhans-CellHematologic DiseasesEmbryonic Stem CellsFlow CytometryBone Marrow DiseasesImmunomagnetic SeparationOpportunistic InfectionsLivedo ReticularisCyclosporineLeukocyte CountPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensAdult Stem Cells